Quality-focused colonoscopy withdrawal techniques
Quality-focused colonoscopy withdrawal techniques has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest paper, Mar 19, 2026: “Implementing key quality performance metrics improves colorectal adenoma detection: Evidence from India”.
1 paper studies it3 findingsUpdated
See all 1 papers on quality-focused colonoscopy withdrawal techniques
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“Independent predictors of adenoma detection included implementation of quality improvement measures (OR 3.3)”
None of its findings points the other way.
- 1 lab in 1 country
- Human trial1
Studies in people
1 study gave quality-focused colonoscopy withdrawal techniques to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
up: Increases colorectal adenoma20.5% vs. 6.3%, OR 3.3, p < 0.0001 up: Increases colorectal polyp32.7% vs. 11.0%, p < 0.0001 no change: Has no effect on colorectal cancer1.8% vs. 2.3%, p = 0.48 | Trial | 2,260 peopleBothmean age 47.3 ± 13.8 yearsGeneral population | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, Mar 19, 2026 |
What did studies of quality-focused colonoscopy withdrawal techniques find?
3Studies of quality-focused colonoscopy withdrawal techniques measured 3 outcomes: colorectal cancer, colorectal polyp and colorectal adenoma.
Colorectal cancer
no changein humans1
1 study
Colorectal cancer
no changein humans1
Quality-focused colonoscopy withdrawal techniques showed no clear effect on colorectal cancer in humans (1.8% vs. 2.3%, p = 0.48).
Human trialn = 2,260
Colorectal polyp
upin humans1
1 study
Colorectal polyp
upin humans1
Quality-focused colonoscopy withdrawal techniques increase colorectal polyp in humans (32.7% vs. 11.0%, p < 0.0001).
Human trialn = 2,260
Colorectal adenoma
upin humans1OR 3.3
1 study
Colorectal adenoma
upin humans1OR 3.3
Quality-focused colonoscopy withdrawal techniques increase colorectal adenoma in humans (20.5% vs. 6.3%, OR 3.3, p < 0.0001).
Human trialn = 2,260